Breast tissue expander-related infections: Perioperative antimicrobial regimens

Infection Control and Hospital Epidemiology

Volumn 35, Issue 1, 2014, Pages 75-81

  Viola, George M ^a   Raad, Issam I ^a   Rolston, Kenneth V ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACITRACIN; CEFALEXIN; CEFAZOLIN; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; GENTAMICIN; POLYMYXIN; SULTAMICILLIN; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BREAST TISSUE EXPANDER; COMORBIDITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MYCOSIS; PROSTHESIS INFECTION; RETROSPECTIVE STUDY; SURGICAL INFECTION;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; FEMALE; HUMANS; MAMMAPLASTY; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PERIOPERATIVE CARE; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; THERAPEUTIC IRRIGATION; TIME FACTORS; TISSUE EXPANSION DEVICES;

EID: 84890480774     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/674390     Document Type: Article

References (40)

1. McGuire KP, Santillan AA, Kaur P, et al. Are mastectomies on the rise? a 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol 2009;16(10):2682-2690.
2. Damle S, Teal CB, Lenert JJ, Marshall EC, Pan Q, McSwain AP. Mastectomy and contralateral prophylactic mastectomy rates: an institutional review. Ann Surg Oncol 2011;18(5):1356-1363.
3. Warren Peled A, Itakura K, Foster RD, et al. Impact of chemotherapy on postoperative complications after mastectomy and immediate breast reconstruction. Arch Surg 2010;145(9):880-885.
4. American Society of Plastic Surgeons (ASPS). 2012 Plastic Surgery Statistics Report. Arlington Heights, IL: ASPS, 2012. http://www.plasticsurgery.org/Documents/news-resources/statistics/2012-P lastic-Surgery-Statistics/full-plastic-surgery-statistics-report.pdf. Accessed August 2, 2013.
5. Halvorson EG, Disa JJ, Mehrara BJ, Burkey BA, Pusic AL, Cordeiro PG. Outcome following removal of infected tissue expanders in breast reconstruction: a 10-year experience. Ann Plast Surg 2007;59(2):131-136.
6. Radovan C. Breast reconstruction after mastectomy using the temporary expander. Plast Reconstr Surg 1982;69(2):195-208.
7. Nahabedian MY, Tsangaris T, Momen B, Manson PN. Infectious complications following breast reconstruction with expanders and implants. Plast Reconstr Surg 2003;112(2):467-476.
8. Pittet B, Montandon D, Pittet D. Infection in breast implants. Lancet Infect Dis 2005;5(2):94-106.
9. Khan UD. Breast augmentation, antibiotic prophylaxis, and infection: comparative analysis of 1,628 primary augmentation mammoplasties assessing the role and efficacy of antibiotics prophylaxis duration. Aesthetic Plast Surg 2010;34(1):42-47.
10. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36(5):309-332.
11. Bratzler DW, Dellinger EP, Olsen KM. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013;70(3):195-283.
12. Cordeiro PG, McCarthy CM. A single surgeon's 12-year experience with tissue expander/implant breast reconstruction. I. A prospective analysis of early complications. Plast Reconstr Surg 2006;118(4):825-831.
13. Armstrong RW, Berkowitz RL, Bolding F. Infection following breast reconstruction. Ann Plast Surg 1989;23(4):284-288.
14. Spear SL, Majidian A. Immediate breast reconstruction in two stages using textured, integrated-valve tissue expanders and breast implants: a retrospective review of 171 consecutive breast reconstructions from 1989 to 1996. Plast Reconstr Surg 1998; 101(1):53-63.
15. Francis SH, Ruberg RL, Stevenson KB. Independent risk factors for infection in tissue expander breast reconstruction. Plast Reconstr Surg 2009;124(6):1790-1796.
16. Handel N, Jensen JA, Black Q, Waisman JR, Silverstein MJ. The fate of breast implants: a critical analysis of complications and outcomes. Plast Reconstr Surg 1995;96(7):1521-1533.
17. Disa JJ, Ad-El DD, Cohen SM, Cordeiro PG, Hidalgo DA. The premature removal of tissue expanders in breast reconstruction. Plast Reconstr Surg 1999;104(6):1662-1665.
18. Cordeiro PG, Pusic AL, Disa JJ, McCormick B, VanZee K. Irradiation after immediate tissue expander/implant breast reconstruction: outcomes, complications, aesthetic results, and satisfaction among 156 patients. Plast Reconstr Surg 2004;113(3): 877-881.
19. Araco A, Gravante G, Araco F, Delogu D, Cervelli V, Walgenbach K. Infections of breast implants in aesthetic breast augmentations: a single-center review of 3,002 patients. Aesthetic Plast Surg 2007;31(4):325-329.
20. Degnim AC, Scow JS, Hoskin TL, et al. Randomized controlled trial to reduce bacterial colonization of surgical drains after breast and axillary operations. Ann Surg 2013;258(2):240-247.
21. Vandeweyer E, Deraemaecker R, Nogaret JM, Hertens D. Immediate breast reconstruction with implants and adjuvant chemotherapy: a good option? Acta Chir Belg 2003;103(1):98-101.
22. Piper M, Peled AW, Foster RD, Moore DH, Esserman LJ. Total skin-sparing mastectomy: a systematic review of oncologic outcomes and postoperative complications. Ann Plast Surg 2013.
23. Reish RG, Damjanovic B, Austen WG Jr, et al. Infection following implant-based reconstruction in 1952 consecutive breast reconstructions: salvage rates and predictors of success. Plast Reconstr Surg 2013;131(6):1223-1230.
24. Mortenson MM, Schneider PD, Khatri VP, et al. Immediate breast reconstruction after mastectomy increases wound complications: however, initiation of adjuvant chemotherapy is not delayed. Arch Surg 2004;139(9):988-991.
25. Tejirian T, DiFronzo LA, Haigh PI. Antibiotic prophylaxis for preventing wound infection after breast surgery: a systematic review and metaanalysis. J Am Coll Surg 2006;203(5):729-734.
26. Throckmorton AD, Hoskin T, Boostrom SY, et al. Complications associated with postoperative antibiotic prophylaxis after breast surgery. Am J Surg 2009;198(4):553-556.
27. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg 2005;189(4):395-404.
28. Feldman EM, Kontoyiannis DP, Sharabi SE, Lee E, Kaufman Y, Heller L. Breast implant infections: is cefazolin enough? Plast Reconstr Surg 2010;126(3):779-785.
29. Phillips BT, Wang ED, Mirrer J, Lanier ST, Khan SU, Dagum AB, Bui DT. Current practice among plastic surgeons of antibiotic prophylaxis and closed-suction drains in breast reconstruction: experience, evidence, and implications for postoperative care. Ann Plast Surg 2011;66(5):460-465.
30. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR; Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 1999;20(4):250-278.
31. Adams WP Jr, Conner WC, Barton FE Jr, Rohrich RJ. Optimizing breast-pocket irrigation: the post-betadine era. Plast Reconstr Surg 2001;107(6):1596-1601.
32. Adams WP Jr, Conner WC, Barton FE Jr, Rohrich RJ. Optimizing breast pocket irrigation: an in vitro study and clinical implications. Plast Reconstr Surg 2000;105(1):334-338.
33. Adams WP Jr, Rios JL, Smith SJ. Enhancing patient outcomes in aesthetic and reconstructive breast surgery using triple antibiotic breast irrigation: six-year prospective clinical study. Plast Reconstr Surg 2006;118(7 suppl):46S-52S.
34. Pfeiffer P, Jorgensen S, Kristiansen TB, Jorgensen A, Holmich LR. Protective effect of topical antibiotics in breast augmentation. Plast Reconstr Surg 2009;124(2):629-634.
35. Washer LL, Gutowski K. Breast implant infections. Infect Dis Clin North Am 2012;26(1):111-125.
36. Zanetti G, Goldie SJ, Platt R. Clinical consequences and cost of limiting use of vancomycin for perioperative prophylaxis: example of coronary artery bypass surgery. Emerg Infect Dis 2001; 7(5):820-827.
37. Elliott RA, Weatherly HL, Hawkins NS, et al. An economic model for the prevention of MRSA infections after surgery: nonglycopeptide or glycopeptide antibiotic prophylaxis? Eur JHealth Econ 2010;11(1):57-66.
38. Cranny G, Elliott R, Weatherly H, et al. A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery. Health Technol Assess 2008;12(1): iii-iv, xi-xii, 1-147.
39. Crawford T, Rodvold KA, Solomkin JS. Vancomycin for surgical prophylaxis? Clin Infect Dis 2012;54(10):1474-1479.
40. Alexander JW, Solomkin JS, Edwards MJ. Updated recommendations for control of surgical site infections. Ann Surg 2011; 253(6):1082-1093.